Qualigen Therapeutics, Inc.
QLGN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$6,359 | -$12,475 | -$11,500 | -$17,897 |
| Dep. & Amort. | $0 | $4 | $12 | $338 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $128 | $1,099 | $0 | $5,294 |
| Change in WC | -$784 | $1,112 | -$643 | $2,213 |
| Other Non-Cash | $687 | -$44 | -$1,116 | -$4,679 |
| Operating Cash Flow | -$6,328 | -$10,304 | -$13,248 | -$14,731 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | -$134 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$1,907 | $4,216 | -$184 | -$7 |
| Investing Cash Flow | -$1,907 | $4,216 | -$184 | -$141 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $1,475 | -$550 | $2,904 | -$139 |
| Stock Issued | $3,053 | $0 | $7 | $8,820 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | -$88 | $0 | $0 | $0 |
| Other Fin. Act. | $4,567 | $0 | -$1 | -$247 |
| Financing Cash Flow | $9,008 | -$550 | $2,911 | $8,434 |
| Forex Effect | $0 | $0 | -$3,851 | $0 |
| Net Chg. in Cash | $773 | -$6,638 | -$14,372 | -$6,438 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $402 | $7,040 | $17,538 | $23,977 |
| End Cash | $1,175 | $402 | $3,166 | $17,538 |
| Free Cash Flow | -$6,328 | -$10,304 | -$13,567 | -$14,872 |